Brain+ A/S develops digital therapeutics for Alzheimer’s and dementia. It develops cognitive stimulation therapy (CST)-Assistant, a health tech solution to support scalable and high-quality delivery of group CST via a readily accessible preparation system, content adaptability and a standardized delivery form, which lessens the dependence of CST performance on therapists; CST - Home Care for use to extend and scale the delivery of CST to a home setting, enabling broader access to the therapy for a larger dementia population at limited costs; CST/ computerized cognitive training (CCT) combination product for individuals with mild cognitive impairment, combining cognitive stimulation therapy with computerized cognitive training to train cognitive function and potentially delay the transition to dementia; and Starry Night, a software based test designed to detect early signs of cognitive decline and enable early targeted intervention and treatment. The company was incorporated in 2012 and is based in Copenhagen, Denmark.